Browse news, stories, events, and press items with a focus on fine chemical supply, quality systems, sustainability reporting, and regulatory documentation.
A firsthand account from a company administrator on how an unexpected search for hydrochloric acid SDS sheets and ethylene dichloride production costs led to a permanent shift in procurement strategy—and why companies like Lonza earn their premium status.
Read moreA firsthand account of a last-minute crisis involving a cell culture medium shortage, and the lessons learned about supplier reliability, process efficiency, and the hidden costs of cutting corners.
Read moreA practical, experience-driven checklist for managing tech transfer in pharma, with a focus on data management and vendor selection. Written by someone who's made (and documented) the mistakes so you don't have to.
Read moreA procurement manager's guide to calculating the true total cost of ownership (TCO) for contract manufacturing, pharma APIs, and cell culture media. Three real-world scenarios for small pharma teams.
Read moreA practical guide from a quality inspector on how to verify product identity, documentation, and specifications when ordering API, media, and fine chemicals from Lonza.
Read moreA practical, no-nonsense guide for pharma and biotech teams evaluating Lonza products and brands. We break down three common scenarios for API and small molecule needs, helping you decide if Lonza is the right fit for your project's scale, timeline, and regulatory stage.
Read moreA quality inspector's practical answers to the most common questions about Lonza's chemical manufacturing, DMEM F12 formulation, and why brand perception matters in the pharma supply chain.
Read moreAn honest look from an administrative buyer on why the cheapest supplier for Lonza products or API manufacturing can end up costing you more. A dive into TCO (Total Cost of Ownership) in the pharma supply chain.
Read moreAn admin buyer's honest take on why pharma compliance training, CRO selection, and vendor management demand specialists—not generalists. Personal experience with Lonza and the industry.
Read moreA practical, step-by-step guide to change control in pharma, based on real mistakes. Includes a downloadable checklist to prevent costly rework and regulatory headaches.
Read more